GLP-1 Pricing Index · formblends network
A dated index of what GLP-1 medication costs in the United States: brand list prices, LillyDirect and NovoCare self-pay tiers, savings-card caps, TrumpRx, Medicare and Medicaid status, employer coverage data, and compounded price ranges by delivery model with a published methodology. Plus a true-monthly-cost calculator that shows its arithmetic.
Interactive
Each runs in your browser, shows its formula, and prints a dated assumptions note. Nothing you type leaves the page.
Reading
Written for people doing the arithmetic themselves: where the mistakes happen, and how to check your own work.
Coverage
Why Medicare Part D could not cover Wegovy or Zepbound for weight loss, which indications it does cover, how the Medicare GLP-1 Bridge works from July 1, 2026 to December 31, 2027 ($50 a month, Wegovy, Zepbound KwikPen, Foundayo, CMS criteria), the indefinitely postponed BALANCE model, the $245 manufacturer price and the $274 negotiated semaglutide price for 2027.
Updated September 4, 2026
Methodology
The rules behind the compounded price table: the unit, the two reference doses, what all-in includes, how prepaid terms and odd billing cycles are converted, the three observation methods and why secondary rows never enter a median, how brand reference prices are kept separate, and how FormBlends' own offer is handled.
Updated September 4, 2026
Methodology
How to turn a per-fill price into a per-dose and per-milligram figure, why the same product costs $7 to $30 per mg depending on the strength, why a 28-day fill is not a month, what a compounded vial's per-mg number needs from the label, and the three situations where per-mg comparisons compare nothing.
Updated September 4, 2026
Methodology
The regulatory, product and pricing differences between compounded semaglutide or tirzepatide and Wegovy, Ozempic, Zepbound or Mounjaro, written by a site whose parent sells the compounded version: what FDA approval covers and compounding does not, what the shortage-resolution dates changed, why compounded prices have no list price, what is inside each price, and how to compare honestly when you must.
Updated September 4, 2026
Prices
One table of the U.S. list price for Zepbound, Mounjaro, Wegovy, Ozempic, the Ozempic pill, Saxenda and Foundayo, what the list price is per, where it was read and when, and what changes on January 1, 2027.
Updated September 4, 2026
Prices
Zepbound (tirzepatide) costs in the United States as of September 4, 2026: the $1,088 list, the $299 to $449 LillyDirect self-pay tiers by strength, the 45-day refill rule, the $25 card with its $100 and $1,300 caps, and the $50 Medicare Bridge for the KwikPen.
Updated September 4, 2026
Browse
Almost nobody pays the list price, and almost every quoted monthly price is really a 28-day price, which is 13 fills a year rather than 12. Savings cards have a floor, a per-fill cap and often an annual cap, so the $25 headline lasts only while the plan pays the rest. Self-pay tiers step up with the dose. Compounded offers bundle fees, memberships and shipping in different ways. Every page here separates those pieces and dates them.
It does not rank providers, recommend a product, or treat compounded and brand prices as prices for the same thing. Compounded semaglutide and tirzepatide are not FDA approved and are not interchangeable with Zepbound, Mounjaro, Wegovy or Ozempic. Prices change without notice; the access date on each figure tells you how fresh it is, and the methodology page tells you how it was collected.
From the FormBlends network
Sister sites